Karyopharm Therapeut
(KPTI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2006 | |
| Sales | 229 | 387 | 634 | 152 | 0 |
| Gross Profit | 229 | 387 | 634 | 152 | N/A |
| Operating Expenses | 76,075 | 34,337 | 16,524 | 10,463 | 0 |
| Operating Income | -75,846 | -33,950 | -15,890 | -10,311 | N/A |
| Interest Expense | 1 | 0 | 0 | 0 | 0 |
| Other Income | 70 | 3 | 2 | 0 | 0 |
| Pre-tax Income | -75,777 | -33,947 | -15,888 | -10,311 | 0 |
| Net Income Continuous | -75,777 | -33,947 | -15,888 | -10,311 | N/A |
| Net Income | $-75,777 | $-33,947 | $-15,888 | $-10,311 | $N/A |
| EPS Basic Total Ops | -36.43 | -83.81 | -134.18 | -153.97 | N/A |
| EPS Basic Continuous Ops | -36.49 | -83.87 | -134.20 | -153.97 | N/A |
| EPS Diluted Total Ops | -36.43 | -83.81 | -134.18 | -153.97 | N/A |
| EPS Diluted Continuous Ops | -36.49 | -83.87 | -134.20 | -153.97 | N/A |
| EBITDA(a) | $-75,521 | $-33,806 | $-15,768 | $-10,228 | $N/A |